LORELCO 250 Pill - white round
Generic Name: probucol
Pill with imprint LORELCO 250 is White, Round and has been identified as Lorelco 250 MG. It is supplied by Aventis Pharmaceuticals.
Lorelco is used in the treatment of High Cholesterol and belongs to the drug class miscellaneous antihyperlipidemic agents. There is no proven risk in humans during pregnancy. Lorelco 250 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for LORELCO 250
Lorelco
- Generic Name
- probucol
- Imprint
- LORELCO 250
- Strength
- 250 MG
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antihyperlipidemic agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aventis Pharmaceuticals
- National Drug Code (NDC)
- 00068-0051 (Discontinued)
See also:
Lipitor
Lipitor is used to treat high cholesterol. Learn about side effects, interactions and indications.
Crestor
Crestor (rosuvastatin) is used to treat high cholesterol and high triglycerides in the blood ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Zetia
Zetia (ezetimibe) is used to treat high cholesterol. Includes Zetia side effects, interactions and ...
Zocor
Zocor (simvastatin) reduces low-density lipoprotein cholesterol and total cholesterol in the blood ...
Colesevelam
Colesevelam is used for diarrhea, chronic, high cholesterol, hyperlipoproteinemia ...
Niacin
Niacin is used to lower cholesterol and triglycerides. Learn about side effects, interactions and ...
Lovastatin
Lovastatin is used for high cholesterol, high cholesterol, familial heterozygous ...
Simvastatin
Simvastatin (Zocor) is a cholesterol-lowering medication that blocks the production of cholesterol ...
More about Lorelco (probucol)
- Check interactions
- Compare alternatives
- Drug images
- Drug class: miscellaneous antihyperlipidemic agents
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.